EXPERIMENTAL TISSUE SHARED RESOURCE
实验组织共享资源
基本信息
- 批准号:7944559
- 负责人:
- 金额:$ 5.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-06 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingCancer CenterCancer Center Support GrantCancer ModelCategoriesClinicalClinical ResearchDoctor of MedicineFigs - dietaryFundingGenetically Engineered MouseGenotypeGoalsGrowthHistologyHumanImageImmunohistochemistryLaboratoriesLasersMalignant NeoplasmsMalignant neoplasm of prostateMarketingMedicineMicroscopyMolecularMusPathologistPathologyPeer ReviewPractice GuidelinesProcessProductivityPublicationsResearch PersonnelResearch Project GrantsResource SharingRodent ModelSamplingServicesSpecimenTechnical ExpertiseTimeTissue BankingTissue BanksTissue ProcurementsTissuesTranslational ResearchUniversity of California Irvine Cancer CenterVendoranimal tissuemedical specialtiesmeetingsmembermorphometrymouse modelprogramstissue resourcetumortumorigenesis
项目摘要
The primary objective of the Experimental Tissue Shared Resource (ETR) is to provide basic, translational,
and clinical researchers within the Cancer Center access to, and analysis of, human and animal tissues. A
key advantage is that this Core leverages the technical and professional expertise of the Department of
Pathology and Laboratory Medicine. Three services are currently offered: i) tissue histology and
immunohistochemistry; ii) tissue banking; and iii) tissue analysis, including laser capture microscopy,
morphometry and image quantitation and genotyping services. Since the Core was initiated in the prior
funding period, 63 CFCCC Members have used it. There has been growth in use, especially in the
histology/immunohistochemistry component, which accounts for the majority of usage within the ETR. In the
prior funding period, the histology component has provided high-quality service at below-market recharge
rates, with short turn-around times to 52 different CFCCC Members who are mainly pursuing translational
research on human cancer specimens or studying rodent models of human cancer. When required, we
customized services to meet the special needs of CFCCC Members. These features have made our
histology services superior to those available from commercial vendors, contributing to usage growth. ETR
services contributed to 43 publications in the prior funding period, including 36 using histology services.
Tissue banking services were used by 21 CFCCC investigators. Analytical services, used by 15
investigators, have been particularly valuable to investigators pursuing translational and clinical research
projects. In this renewal, we propose to expand to meet an increased demand for histology services,
maintain our specialty analytical services, strengthen our tissue procurement activities by focusing on
comprehensively banking prostate cancers and provide a new mouse pathology service which will assist
CFCCC investigators in the initial characterization of genetically engineered mouse models of human
cancer.
实验组织共享资源(ETR)的主要目标是提供基本的,翻译的,
和癌症中心的临床研究人员获得和分析人类和动物组织。一
一个关键的优势是,这一核心利用了国防部的技术和专业知识,
病理学和实验室医学。目前提供三种服务:i)组织组织学和
免疫组织化学; ii)组织建库;和iii)组织分析,包括激光捕获显微术,
形态测定和图像定量和基因分型服务。由于核心是在前一个
在资助期内,已有63个CFCCC成员使用了它。使用量有所增长,特别是在
组织学/免疫组织化学成分,占ETR内的大部分使用。在
在上一个供资期间,组织学部分以低于市场的收费提供了高质量的服务
52个不同的CFCCC成员主要从事翻译工作,
研究人类癌症标本或研究人类癌症的啮齿动物模型。如果需要,我们
定制服务,满足CFCCC会员的特殊需求。这些特点使我们的
组织学服务比商业供应商提供的服务更上级,有助于使用增长。ETR
在上一个供资期间,组织学服务部门为43份出版物提供了捐助,其中36份使用了组织学服务。
21名CFCCC研究者使用了组织库服务。分析服务,15个国家使用
对于从事转化和临床研究的研究者来说,
项目在这次更新中,我们建议扩大以满足对组织学服务日益增长的需求,
保持我们的专业分析服务,通过专注于
全面银行前列腺癌,并提供一个新的小鼠病理学服务,这将有助于
CFCCC研究人员在人类基因工程小鼠模型的初步表征
癌
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John J. Krolewski其他文献
John J. Krolewski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John J. Krolewski', 18)}}的其他基金
An Androgen-Regulated Cytokine Network Controls Prostate Apoptosis.
雄激素调节的细胞因子网络控制前列腺细胞凋亡。
- 批准号:
9115277 - 财政年份:2011
- 资助金额:
$ 5.15万 - 项目类别:
An androgen-regulated cytokine network controls prostate apoptosis
雄激素调节的细胞因子网络控制前列腺细胞凋亡
- 批准号:
8549718 - 财政年份:2011
- 资助金额:
$ 5.15万 - 项目类别:
An androgen-regulated cytokine network controls prostate apoptosis
雄激素调节的细胞因子网络控制前列腺细胞凋亡
- 批准号:
8187541 - 财政年份:2011
- 资助金额:
$ 5.15万 - 项目类别:
An androgen-regulated cytokine network controls prostate apoptosis
雄激素调节的细胞因子网络控制前列腺细胞凋亡
- 批准号:
8735868 - 财政年份:2011
- 资助金额:
$ 5.15万 - 项目类别:
TYK2 AND IFNAR1 IN INTERFERON ALPHA SIGNALING
干扰素 α 信号转导中的 TYK2 和 IFNAR1
- 批准号:
6475792 - 财政年份:1992
- 资助金额:
$ 5.15万 - 项目类别:
TYK2 TYROSINE KINASE--NORMAL AND PATHOLOGIC FUNCTION
TYK2 酪氨酸激酶——正常和病理功能
- 批准号:
2774052 - 财政年份:1992
- 资助金额:
$ 5.15万 - 项目类别:
Signaling via proteolysis of the interferon receptor
通过干扰素受体的蛋白水解传递信号
- 批准号:
7252514 - 财政年份:1992
- 资助金额:
$ 5.15万 - 项目类别:
相似海外基金
UF Health Cancer Center Support Grant - Training Navigator Supplement
佛罗里达大学健康癌症中心支持补助金 - 培训导航补充
- 批准号:
10892335 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
乔治城大学隆巴迪综合癌症中心支持补助金
- 批准号:
10771760 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
University of Florida Health Cancer Center Support Grant
佛罗里达大学健康癌症中心支持补助金
- 批准号:
10625750 - 财政年份:2023
- 资助金额:
$ 5.15万 - 项目类别:
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
乔治城大学隆巴迪综合癌症中心支持补助金
- 批准号:
10619774 - 财政年份:2022
- 资助金额:
$ 5.15万 - 项目类别:
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
乔治城大学隆巴迪综合癌症中心支持补助金
- 批准号:
10405729 - 财政年份:2022
- 资助金额:
$ 5.15万 - 项目类别:
ETCTN Early Drug Development Opportunity Leadership program administrative supplement to Cancer Center Support Grant
ETCTN 早期药物开发机会领导计划对癌症中心支持补助金的行政补充
- 批准号:
10363981 - 财政年份:2021
- 资助金额:
$ 5.15万 - 项目类别:
University of Colorado Cancer Center Support Grant
科罗拉多大学癌症中心支持补助金
- 批准号:
10371494 - 财政年份:2021
- 资助金额:
$ 5.15万 - 项目类别:
University of Colorado Cancer Center Support Grant - CTRAC Supplement Yr 02
科罗拉多大学癌症中心支持补助金 - CTRAC 补充第 02 年
- 批准号:
10439981 - 财政年份:2021
- 资助金额:
$ 5.15万 - 项目类别: